220 related articles for article (PubMed ID: 37410790)
21. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
Xiao SH; Sun J; Chen MG
Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
[TBL] [Abstract][Full Text] [Related]
22. The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum.
Xiao SH; Mei JY; Jiao PY
Parasitol Res; 2009 Dec; 106(1):237-46. PubMed ID: 19851783
[TBL] [Abstract][Full Text] [Related]
23. Schistosoma japonicum: treatment of different developmental stages in mice with long-acting praziquantel implants.
Cheng L; Lei L; Guo S; Zhu C; Rong H; Guo D; Zhang L; Jiang Y; Lin J
Exp Parasitol; 2011 Nov; 129(3):254-9. PubMed ID: 21856298
[TBL] [Abstract][Full Text] [Related]
24. In vivo praziquantel efficacy of Schistosoma japonicum over time: A systematic review and meta-analysis.
Yu QF; Zhang JY; Sun MT; Gu MM; Zou HY; Webster JP; Lu DB
Acta Trop; 2021 Oct; 222():106048. PubMed ID: 34273315
[TBL] [Abstract][Full Text] [Related]
25. Use of kinase inhibitors against schistosomes to improve and broaden praziquantel efficacy.
Nawaratna SSK; McManus DP; Gasser RB; Brindley PJ; Boyle GM; Rivera V; Ranasinghe SL; Jones MK; You H; Gobert GN
Parasitology; 2020 Nov; 147(13):1488-1498. PubMed ID: 32741402
[TBL] [Abstract][Full Text] [Related]
26. Development of chiral praziquantel analogues as potential drug candidates with activity to juvenile Schistosoma japonicum.
Zheng Y; Dong L; Hu C; Zhao B; Yang C; Xia C; Sun D
Bioorg Med Chem Lett; 2014 Sep; 24(17):4223-6. PubMed ID: 25127102
[TBL] [Abstract][Full Text] [Related]
27. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
28. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.
Wang W; Li TY; Ji Y; Qu GL; Qian YL; Li HJ; Dai JR; Liang YS
Parasitol Res; 2014 Mar; 113(3):925-31. PubMed ID: 24326467
[TBL] [Abstract][Full Text] [Related]
30. Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.
Xiao SH; Mei JY; Jiao PY
Parasitol Res; 2011 Feb; 108(2):399-406. PubMed ID: 20922425
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of schistosomicidal potential of curcumin against Schistosoma japonicum.
Chen YQ; Xu QM; Li XR; Yang SL; Zhu-Ge HX
J Asian Nat Prod Res; 2012; 14(11):1064-72. PubMed ID: 23088385
[TBL] [Abstract][Full Text] [Related]
32. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis.
Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA
Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735
[TBL] [Abstract][Full Text] [Related]
33. An artemisinin derivative of praziquantel as an orally active antischistosomal agent.
Dong L; Duan W; Chen J; Sun H; Qiao C; Xia CM
PLoS One; 2014; 9(11):e112163. PubMed ID: 25386745
[TBL] [Abstract][Full Text] [Related]
34. Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with
Chen TT; Peng S; Wang Y; Hu Y; Shen Y; Xu Y; Yin J; Liu C; Cao J
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31717714
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of different isolates of Schistosoma japonicum from China to praziquantel.
He YX; Hu YQ; Yu QF
Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):261-3. PubMed ID: 1439978
[TBL] [Abstract][Full Text] [Related]
36. Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort study.
Colt S; Jarilla B; Baltazar P; Tallo V; Acosta LP; Wu HW; Barry CV; Kurtis JD; Olveda RM; Friedman JF; Jiz MA
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009328. PubMed ID: 33861768
[TBL] [Abstract][Full Text] [Related]
37. Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?
Wang W; Li HJ; Qu GL; Xing YT; Yang ZK; Dai JR; Liang YS
Parasitol Res; 2014 Jan; 113(1):223-8. PubMed ID: 24146208
[TBL] [Abstract][Full Text] [Related]
38. In vivo efficiency of praziquantel treatment of single-sex Schistosoma japonicum aged three months old in mice.
Wang N; Peng HQ; Gao CZ; Cheng YH; Sun MT; Qu GL; Webster JP; Lu DB
Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():129-134. PubMed ID: 36403362
[TBL] [Abstract][Full Text] [Related]
39. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
40. Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.
Meister I; Ingram-Sieber K; Cowan N; Todd M; Robertson MN; Meli C; Patra M; Gasser G; Keiser J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5466-72. PubMed ID: 24982093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
